Helping Chemists Discover New Antibiotics

Area of Science:

• Drug discovery and development
• Antimicrobial resistance
• Synthetic chemistry

Background:

• The rise of drug-resistant bacteria, or "superbugs," poses a critical global health threat.
• There is an urgent need for novel antibiotics due to a declining development pipeline.
• Existing strategies for antibiotic discovery are insufficient to meet the growing challenge.

Purpose of the Study:

• To propose a new strategy for reinvigorating antibiotic research and development.
• To encourage synthetic chemists to contribute their chemical libraries for antimicrobial screening.
• To introduce the Community for Open Antimicrobial Drug Discovery (CO-ADD) as a resource.

Main Methods:

• Leveraging the chemical diversity available in synthetic chemistry laboratories.
• Utilizing the CO-ADD platform for high-throughput screening of compounds.
• Conducting follow-up hit confirmation and validation for promising candidates.

Main Results:

• CO-ADD provides free, open-access screening services.
• The initiative facilitates the identification of novel antimicrobial compounds.
• Collaboration between synthetic chemists and drug discovery programs is fostered.

Conclusions:

• Engaging synthetic chemists is a viable strategy to expand the antibiotic discovery pipeline.
• Open-access platforms like CO-ADD can accelerate the identification of new antimicrobial agents.
• Addressing the antimicrobial resistance crisis requires innovative, collaborative approaches.